Company Filing History:
Years Active: 2009-2014
Title: Innovations of John A. Stonik
Introduction
John A. Stonik is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biochemistry, particularly in the development of peptides that have therapeutic applications. With a total of 4 patents, his work focuses on innovative methods to promote lipid efflux and treat various disorders.
Latest Patents
Stonik's latest patents include groundbreaking research on multi-domain amphipathic helical peptides. These peptides or peptide analogs possess multiple amphipathic α-helical domains that facilitate lipid efflux from cells through an ABCA1-dependent pathway. His patents also detail methods for using these peptides to treat or inhibit dyslipidemic disorders. Additionally, he has developed methods for identifying non-cytotoxic peptides that promote ABCA1-dependent lipid efflux from cells. Another significant patent involves treating or inhibiting inflammation using similar multi-domain amphipathic helical peptides.
Career Highlights
John A. Stonik is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to explore innovative solutions to complex health issues. His research has the potential to impact the treatment of various lipid-related disorders significantly.
Collaborations
Stonik has collaborated with esteemed colleagues such as Alan Thomas Remaley and Stephen J. Demosky. These collaborations have further enriched his research and contributed to the advancement of knowledge in his field.
Conclusion
John A. Stonik's innovative work in peptide research exemplifies the intersection of science and health. His contributions are paving the way for new therapeutic approaches to treat dyslipidemic disorders and inflammation.